republic-os/legislation/us/states/tn/112/sb-2240.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Controlled Substances - As enacted, prohibits a healthcare provider who is authorized to prescribe buprenorphine under federal law from prescribing via telehealth a buprenorphine product, as approved by the federal food and drug administration for use in recovery or medication-assisted treatment, unless certain conditions met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.	Controlled Substances - As enacted, prohibits a healthcare provider who is authorized to prescribe buprenorphine under federal law from prescribing via telehealth a buprenorphine product, as approved by the federal food and drug administration for use in recovery or medication-assisted treatment, unless certain conditions met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.	us/states/tn	Tennessee General Assembly	112	SB 2240	Tennessee SB 2240 (112)	bill	Controlled Substances	enacted	Haile Vaughan	3	41	6	2022-02-01	2022-04-26	openstates	ocd-bill/ca27ad67-6053-443c-aa7b-ecef232244bc	http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=SB2240&GA=112	4582e66c64942ad1bcde02c13f501cf7dcd8aaa43863f5b0b0be64c43f7aa80e	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-tn

Tennessee SB 2240 (112) — Controlled Substances - As enacted, prohibits a healthcare provider who is authorized to prescribe buprenorphine under federal law from prescribing via telehealth a buprenorphine product, as approved by the federal food and drug administration for use in recovery or medication-assisted treatment, unless certain conditions met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Amendment HA0790 (committee substitute) — source
2. Amendment SA0754 (committee substitute) — source
3. Current Version (committee substitute) — source

Votes

• HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Regular Calendar for 4/4/2022 3/31/2022 (2) — 0–0 (fail) · lower
• FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/4/2022 Passed (1) — 93–0 (pass) · lower
• HOUSE HEALTH SUBCOMMITTEE: Rec for pass if am by s/c ref. to Health Committee 3/15/2022 (4) — 0–0 (fail) · lower
• HOUSE HEALTH COMMITTEE: Rec. for pass. if am., ref. to Calendar & Rules Committee 3/23/2022 (3) — 0–0 (pass) · lower
• FLOOR VOTE: as Amended Third Consideration 3/31/2022 Passed (1) — 30–0 (pass) · upper
• SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/23/2022 Passed (2) — 9–0 (pass) · upper

Sponsors

• Haile — primary (person)
• Vaughan — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2022-02-01 Filed for introduction introduction, reading-1
• 2022-02-01 Filed for introduction introduction, reading-1
• 2022-02-02 Introduced, Passed on First Consideration introduction
• 2022-02-02 Intro., P1C. introduction
• 2022-02-03 Passed on Second Consideration, refer to Senate Health and Welfare Committee
• 2022-02-03 P2C, ref. to Health Committee referral-committee
• 2022-02-07 Assigned to s/c Health Subcommittee referral-committee
• 2022-02-09 Sponsor(s) Added.
• 2022-03-02 Placed on Senate Health and Welfare Committee calendar for 3/9/2022
• 2022-03-02 Placed on s/c cal Health Subcommittee for 3/8/2022
• 2022-03-08 Action Def. in s/c Health Subcommittee to 3/15/2022
• 2022-03-09 Action deferred in Senate Health & Welfare Committee to next calendar
• 2022-03-09 Placed on s/c cal Health Subcommittee for 3/15/2022
• 2022-03-15 Rec for pass if am by s/c ref. to Health Committee referral-committee
• 2022-03-16 Placed on Senate Health and Welfare Committee calendar for 3/23/2022
• 2022-03-16 Placed on cal. Health Committee for 3/23/2022
• 2022-03-23 Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
• 2022-03-23 Sponsor(s) Added.
• 2022-03-23 Rec. for pass. if am., ref. to Calendar & Rules Committee committee-passage-favorable
• 2022-03-28 Placed on Senate Regular Calendar for 3/30/2022
• 2022-03-30 Placed on Senate Regular Calendar for 3/31/2022
• 2022-03-30 Senate Reset on calendar for 3/31/2022
• 2022-03-30 Placed on cal. Calendar & Rules Committee for 3/31/2022
• 2022-03-31 Engrossed; ready for transmission to House
• 2022-03-31 Passed Senate as amended, Ayes 30, Nays 0 passage
• 2022-03-31 Senate adopted Amendment (Amendment 1 - SA0754)
• 2022-03-31 H. Placed on Regular Calendar for 4/4/2022
• 2022-04-04 Passed H., Ayes 93, Nays 0, PNV 0 passage
• 2022-04-04 Am. withdrawn. (Amendment 1 - HA0790) amendment-withdrawal
• 2022-04-04 Subst. for comp. HB.
• 2022-04-04 Rcvd. from S., held on H. desk.
• 2022-04-04 Comp. SB subst.
• 2022-04-04 Sponsor(s) Added.
• 2022-04-05 Signed by Senate Speaker
• 2022-04-05 Enrolled and ready for signatures
• 2022-04-06 Signed by H. Speaker
• 2022-04-07 Transmitted to Governor for action.
• 2022-04-14 Signed by Governor. executive-signature
• 2022-04-26 Effective date(s) 04/14/2022
• 2022-04-26 Pub. Ch. 881
• 2022-04-26 Comp. became Pub. Ch. 881

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ca27ad67-6053-443c-aa7b-ecef232244bc. Confidence: reported (aggregated from official Tennessee legislature records).